Cargando…
Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase
Nucleic Acid Therapeutics (NATs), including siRNAs and AntiSense Oligonucleotides (ASOs), have great potential to drug the undruggable genome. Targeting siRNAs and ASOs to specific cell types of interest has driven dramatic improvement in efficacy and reduction in toxicity. Indeed, conjugation of tr...
Autores principales: | Huggins, Ian J., Medina, Carlos A., Springer, Aaron D., van den Berg, Arjen, Jadhav, Satish, Cui, Xianshu, Dowdy, Steven F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767100/ https://www.ncbi.nlm.nih.gov/pubmed/31509944 http://dx.doi.org/10.3390/molecules24183287 |
Ejemplares similares
-
Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminase
por: Hadjabdelhafid-Parisien, Adem, et al.
Publicado: (2022) -
Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021) -
Synthesis of Site-Specific
Antibody–[60]Fullerene–Oligonucleotide
Conjugates for Cellular Targeting
por: Äärelä, Antti, et al.
Publicado: (2023) -
Oligonucleotide conjugated antibody strategies for cyclic immunostaining
por: Jones, Jocelyn A., et al.
Publicado: (2021) -
Synthesis of Azide-Modified Chondroitin Sulfate Precursors:
Substrates for “Click”- Conjugation with Fluorescent
Labels and Oligonucleotides
por: Jadhav, Satish, et al.
Publicado: (2018)